Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 1.00 |
| ▸ | MEN1 | O00255 | 3/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
| ▸ | TSHR | P16473 | 2/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 2/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 2/20 | 1.00 |
| ▸ | PDK1 | Q15118 | 1/20 | 1.00 |
| ▸ | PDK2 | Q15119 | 1/20 | 1.00 |
| ▸ | PDK3 | Q15120 | 1/20 | 1.00 |
| ▸ | PDK4 | Q16654 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.98 |
| ▸ | TP53 | P04637 | 1/20 | 0.98 |
| ▸ | MAPT | P10636 | 1/20 | 0.98 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.98 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.79 |
| ▸ | KARS1 | Q15046 | 3/20 | 0.79 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.66 |
| ▸ | LMNA | P02545 | 1/20 | 0.65 |
| ▸ | RXRA | P19793 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17158674 | 1.00 | CYP3A4 (1.00) | CYP3A4MEN1KMT2ATSHRCYP2D6 | |
| SCHEMBL9108470 | 1.00 | CYP3A4 (1.00) | CYP3A4MEN1KMT2ATSHRCYP2D6 | |
| SCHEMBL14029315 | 1.00 | CYP3A4 (1.00) | CYP3A4MEN1KMT2ATSHRCYP2D6 | |
| SCHEMBL31682257 | 1.00 | CYP3A4 (1.00) | CYP3A4MEN1KMT2ATSHRCYP2D6 | |
| SCHEMBL29380336 | 1.00 | CYP3A4 (1.00) | CYP3A4MEN1KMT2ATSHRCYP2D6 | |
| SCHEMBL27864 | 1.00 | CYP3A4 (1.00) | CYP3A4MEN1KMT2ATSHRCYP2D6 | |
| SCHEMBL27863 | 1.00 | CYP3A4 (1.00) | CYP3A4MEN1KMT2ATSHRCYP2D6 | |
| Hydrochloric Acid SCHEMBL29409504 | 0.99 | CYP3A4 (1.00) | CYP3A4MEN1KMT2ATSHRCYP2D6 | |
| SCHEMBL5933820 | 0.99 | CYP3A4 (0.98) | CYP3A4MEN1KMT2ATSHRCYP2D6 | |
| SCHEMBL17453400 | 0.99 | CYP3A4 (0.98) | CYP3A4MEN1KMT2ATSHRCYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9410074-B2 | Compositions and methods for inhibiting naphthenate solids formation from liquid hydrocarbons | M-I L.L.C. (US) | 2016-08-09 | — | — | US | claimed |
| EP-2504407-B1 | COMPOSITIONS AND METHODS FOR INHIBITING NAPHTHENATE SOLIDS FORMATION FROM LIQUID HYDROCARBONS | M I AUSTRALIA PTY LTD (AU) | 2015-03-25 | — | — | EP | claimed |
| US-20120310022-A1 | Compositions And Methods For Inhibiting Naphthenate Solids Formation From Liquid Hydrocarbons | M-I L. L. C. | 2012-12-06 | — | — | US | claimed |
| WO-2024043223-A1 | FLUX AND METHOD FOR PRODUCING BONDED OBJECT | 千住金属工業株式会社 | 2024-02-29 | — | — | WO | disclosed |
| WO-2024043231-A1 | FLUX AND METHOD FOR PRODUCING ELECTRONIC COMPONENT | 千住金属工業株式会社 | 2024-02-29 | — | — | WO | disclosed |
| US-20230302586-A1 | FLUX AND SOLDER PASTE | SENJU METAL INDUSTRY CO., LTD. (JP) | 2023-09-28 | — | — | US | disclosed |
| US-20230302586-A1 | FLUX AND SOLDER PASTE | SENJU METAL INDUSTRY CO., LTD. (JP) | 2023-09-28 | — | — | US | disclosed |
| WO-2023171471-A1 | FLUX AND SOLDER PASTE | 千住金属工業株式会社 | 2023-09-14 | — | — | WO | disclosed |
| WO-2023106188-A1 | FLUX AND METHOD FOR PRODUCING ASSEMBLY | 千住金属工業株式会社 | 2023-06-15 | — | — | WO | disclosed |
| WO-2023080150-A1 | FLUX AND PRODUCTION METHOD FOR JOINED BODY | 千住金属工業株式会社 | 2023-05-11 | — | — | WO | disclosed |
| US-20230067289-A1 | ELASTOMERIC COMPOSITION REINFORCED WITH GROUND-BIOCHAR | COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) | 2023-03-02 | — | — | US | disclosed |
| US-20070130703-A1 | Bringing fiber material into contact with at least one reactive dye containing at least one anionic group, at least one compound which reduces the ionic character of the anionic group, and at least one nucleophilic compound; yields dyeings or prints having deep hues and very good fastness | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2007-06-14 | — | — | US | disclosed |
| US-20040102488-A1 | Butenolide and pentenolide derivatives as kinase inhibitors | MORPHOCHEM AG (DE) | 2004-05-27 | — | — | US | disclosed |
| US-6545040-B1 | Method of lowering the blood pressure | JANSSEN PHARMACEUTICA N.V. (BE) | 2003-04-08 | — | — | US | disclosed |
| EP-0334429-B1 | AGENTS FOR LOWERING THE BLOOD PRESSURE | JANSSEN PHARMACEUTICA N.V. (BE) | 1992-11-19 | — | — | EP | disclosed |
| US-5153069-A | For pigments | Canestri, Giuseppe (IT) | 1992-10-06 | — | — | US | disclosed |
| EP-0189385-B1 | POLYESTERAMIDE DISPERSING AGENT | Canestri, Giuseppe, Dr. (IT) | 1991-05-02 | — | — | EP | disclosed |
| US-4999132-A | For organic pigments, inks, paints | BERGVIK KEMI AB (SE) | 1991-03-12 | — | — | US | disclosed |
| EP-0334429-A1 | Agents for lowering the blood pressure | JANSSEN PHARMACEUTICA N.V. (BE) | 1989-09-27 | — | — | EP | disclosed |
| EP-0189385-A2 | Polyesteramide dispersing agent | Canestri, Giuseppe, Dr. (IT) | 1986-07-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120310022-A1 | Compositions And Methods For Inhibiting Naphthenate Solids Formation From Liquid Hydrocarbons | NR4A1, NR4A2, NR0B1 | CYP3A4 54/4885MEN1 1819/4885KMT2A 2258/4885 |
| US-20040102488-A1 | Butenolide and pentenolide derivatives as kinase inhibitors | MAP3K20, MAP3K21, MAP3K1 | CYP3A4 1647/4885MEN1 2347/4885KMT2A 3752/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.